Investing Profile

Corey Goodman

InvestorVCAngel
Managing Partner at venBio
venbio.com/corey.htmlSan Francisco, California
Photo of Corey Goodman, Managing Partner at venBio

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
venBio Managing Partner
$20.0M - $30.0M
$25.0M
17
CompanyStageDateRound SizeTotal Raised
Parabilis Medicines
Series FJan 2026$310M
Series EMar 2024$150M
Series DNov 2022$180M
Series CJan 2021$110M
$740M
Co-investors: Thilo Schroeder (Nextech Invest)
Insamo
SeedFeb 2024$12M
$12M
Co-investors: Matt Hershenson (Playground Global)
MindRhythm
SeedAug 2021$5M
$5M
Tallac Therapeutics
Series ADec 2020$62M
$62M
Checkmate Pharmaceuticals
Series CJun 2020$85M
Series CDec 2018$22M
Series BJun 2017$27M
Series AAug 2015$20M
$150M
Co-investors: Ben Auspitz (F-Prime Capital Partners), Michael Powell (Omega Funds), Daniel Coley (Cofounders Capital)
ALX Oncology
Series CFeb 2020$110M
Convertible NoteMar 2017$25M
Series AMar 2015$36M
$170M
Co-investors: Jack Nielsen (Vivo Capital)
Queenly
Pre SeedOct 2019$800K
$2.8M
Co-investors: Shayna Modarresi (Runway Growth Capital), Gustaf Alströmer (Y Combinator), Ralph Gootee, Jon Brelig, James Park, Jason Wang
Good2Go, Inc
SeedSep 2017$7M
$7M
Co-investors: Shailesh Rao (BigSpring)
Managing Partner venBio PartnersPresent